1. Taking Stock of a Maturing CGT Sector.
- Author
-
Mirasol, Feliza
- Subjects
GENE therapy ,PATIENT safety ,PHARMACEUTICAL technology ,CELLULAR therapy ,MEDICAL societies ,CONFERENCES & conventions ,BUSINESS ,DRUG design ,DRUG efficacy ,DRUG development - Abstract
The article offers information on recent advancements in the development and manufacturing of cell and gene therapies (CGTs), highlighted at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2024. Topics include efforts to enhance therapeutic efficacy, purity, and safety of gene therapies, focusing on strategies like detargeting adeno-associated viruses (AAVs) from the liver to reduce liver damage and enhance tissue targeting.
- Published
- 2024